None listed
Conditions
Brief summary
Oral ketamine has been used for many years as a treatment for chronic pain. Evidence supports the efficacy and relative safety of short to medium term use ( one year) for patients with intractable chronic pain. The aim of this study is to carry out an audit of these patients to assess the safety and efficacy of long-term oral ketamine therapy
Interventions
Questionnaires will be administered: Brief Pain Inventory, Depression and Anxiety Stress Scale, Pain Catastrophizing Scale and Pain Self-efficacy Questionnaire. Patients will also complete a check list of side effects from ketamine treatment. Demographic data will be extracted from Dr Salmons case notes, as well as other analgesia prescribed and patients perception of effects of treatment. Questionnaire responses will be compared with baseline questionnaires (PCS, PSEC, BPI and DASS ) completed at initial consultation when the patients first consults with Dr Salmon whenever that appointment occurred. The length of time each patients have been taking will vary, however patients consenting to the study are at least two years post commencement of ketamine therapy. The participating patients are only required to complete one set of questionnaires in addition to the initial (first consultation) questionnaires which is standard care. Patients are approached when attending clinic for follow-up appointments , or contacted by telephone.
Sponsors
Eligibility
Inclusion criteria
All patients with treatment resistant severe chronic pain treated by Dr Salmon for at least two years with oral ketamine therapy
Exclusion criteria
Unable to give informed consent. Less than 2 years treatment with ketamine oral medication.